CSB 2.010 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats., Register July 2021 No. 787; CR 22-040: cr. Register June 2023 No. 810, eff. 7-1-23. CSB 2.010 NoteCSB 2.91 Addition of 4,4’-Dimethylaminorex to schedule I. Section 961.14 (7) (cm), Stats., is created to read: CSB 2.010 Note961.14 (7) (cm) 4,4’-Dimethylaminorex.
CSB 2.010 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register September 2021 No. 789, eff. 9-27-21; CR 22-054: cr. Register June 2023 No. 810, eff. 7-1-23. CSB 2.010 NoteCSB 2.92 Addition of thirty-five (35) Anabolic Steroids to schedule III. Section 961.18 (7), Stats., is repealed and recreated to read:
CSB 2.010 Note961.18 (7) Anabolic steroids. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation containing any quantity of any of the following anabolic steroids, including any of their esters, ethers, isomers, esters or ethers of isomers, salts and salts of esters or ethers, isomers and esters or ethers of isomers that are theoretically possible within the specific chemical designation. Except such terms do not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the Secretary of Health and Human Services for such administration. If any person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this section:
CSB 2.010 Note(a) 3beta,17-dihydroxy-5alpha-androstane.
CSB 2.010 Note(ag) 3alpha,17beta-dihydroxy-5alpha-androstane.
CSB 2.010 Note(ar) 5alpha-androstan-3,17-dione.
CSB 2.010 Note(b) 1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene; 3alpha,17beta-dihydroxy-5alpha-androst-1-ene).
CSB 2.010 Note(bg) 4-androstenediol.
CSB 2.010 Note(br) 5-androstenediol.
CSB 2.010 Note(c) 1-androstenedione.
CSB 2.010 Note(cg) 4-androstenedione.
CSB 2.010 Note(cr) 5-androstenedione.
CSB 2.010 Note(d) Bolasterone.
CSB 2.010 Note(dg) Boldenone.
CSB 2.010 Note(dr) Boldione.
CSB 2.010 Note(e) Calusterone.
CSB 2.010 Note(eg) 4-chlorotestosterone, which is also called clostebol.
CSB 2.010 Note(er) Dehydrochloromethyltestosterone.
CSB 2.010 Note(f) Desoxymethyltestosterone.
CSB 2.010 Note(fg) Delta1-dihydrotestosterone.
CSB 2.010 Note(fr) 4-dihydrotestosterone, which is also called stanolone.
CSB 2.010 Note(g) Drostanolone.
CSB 2.010 Note(gg) Ethylestrenol.
CSB 2.010 Note(gr) Fluoxymesterone.
CSB 2.010 Note(h) Formebulone, which is also called fromebolone.
CSB 2.010 Note(hg) Furazabol.
CSB 2.010 Note(hr) 13beta-ethyl-17beta-hydroxygon-4-en-3-one.
CSB 2.010 Note(i) 4-hydroxytestosterone.
CSB 2.010 Note(ig) 4-hydroxy-19-nortestosterone.
CSB 2.010 Note(ir) Mestanolone.
CSB 2.010 Note(j) Mesterolone.
CSB 2.010 Note(jg) Methandienone, which is also called methandrostenolone.
CSB 2.010 Note(jr) Methandriol.
CSB 2.010 Note(k) Methasterone.
CSB 2.010 Note(kg) Methenolone.
CSB 2.010 Note(kr) 17alpha-methyl-3beta, 17beta-dihydroxy-5alpha-androstane.
CSB 2.010 Note(L) 17alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane.
CSB 2.010 Note(Lg) 17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene.
CSB 2.010 Note(Lr) 17alpha-methyl-4-hydroxynandrolone.
CSB 2.010 Note(m) Methyldienolone.
CSB 2.010 Note(mg) Methyltestosterone.
CSB 2.010 Note(mr) Methyltrienolone.
CSB 2.010 Note(n) Mibolerone.
CSB 2.010 Note(ng) 17alpha-methyl-delta1-dihydrotestosterone, which is also called 17-alpha-methyl-1-testosterone.
CSB 2.010 Note(nr) Nandrolone.
CSB 2.010 Note(o) 19-nor-4-androstenediol (3beta, 17beta-dihydroxyestr-4-ene; 3alpha, 17beta-dihydroxyestr-4-ene).
CSB 2.010 Note(og) 19-nor-5-androstenediol (3beta, 17beta-dihydroxyestr-5-ene; 3alpha, 17beta-dihydroxyestr-5-ene).
CSB 2.010 Note(or) 19-nor-4,9(10)-androstadienedione.
CSB 2.010 Note(p) 19-nor-4-androstenedione (estr-4-en-3,17-dione).
CSB 2.010 Note(pg) 19-nor-5-androstenedione (estr-5-en-3,17-dione).
CSB 2.010 Note(pr) Norbolethone.
CSB 2.010 Note(q) Norclostebol.
CSB 2.010 Note(qg) Norethandrolone.
CSB 2.010 Note(qr) Normethandrolone.
CSB 2.010 Note(r) Oxandrolone.
CSB 2.010 Note(rg) Oxymesterone.
CSB 2.010 Note(rr) Oxymetholone.
CSB 2.010 Note(s) Prostanozol.
CSB 2.010 Note(sg) Stanozolol.
CSB 2.010 Note(sr) Stenbolone.
CSB 2.010 Note(t) Testolactone.
CSB 2.010 Note(tg) Testosterone.
CSB 2.010 Note(tr) Tetrahydrogestrinone.
CSB 2.010 Note(u) Trenbolone.
CSB 2.010 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-018: cr. Register April 2024 No. 820, eff. 5-1-24. CSB 2.010 NoteCSB 2.93 Addition of Daridorexant to schedule IV. Section 961.20 (2) (cpm), Stats., is created to read: CSB 2.010 Note961.20 (2) (cpm) Daridorexant;
CSB 2.010 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-019: cr. Register April 2024 No. 820, eff. 5-1-24; correction made under s. 35.17, Stats., Register April 2024 No. 820. CSB 2.010 NoteCSB 2.94 Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I. (1) Section 961.14 (2) (mm) and (pe), Stats., are renumbered to 961.14 (2) (xm) 3. and 5. and amended to read:
CSB 2.010 Note961.14 (2) (xm) 3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
CSB 2.010 Note961.14 (2) (xm) 5. Isotonitazene (N,N -diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benizimidazol-1-yl)ethan-1-amine).
CSB 2.010 Note.14 (2) (xm) Synthetic Benzimidazole-opioid Substances, specifically including all of the following:
CSB 2.010 Note1. Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
CSB 2.010 Note2. Etodesnitazene also known as Etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
CSB 2.010 Note4. Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1- amine).
CSB 2.010 Note6. Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).
CSB 2.010 Note7. Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).
CSB 2.010 Note8. N-pyrrolidino etonitazene also known as etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)-1H-benzimidazole).
CSB 2.010 Note9. Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).
CSB 2.010 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction in numbering of (1), (2) made under s. 13.92 (4) (b) 1., Stats., and correction in (1) made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-020: cr. Register April 2024 No. 820, eff. 5-1-24; correction made under s. 35.17, Stats., Register April 2024 No. 820. CSB 2.010 NoteCSB 2.95 Addition of Ganaxolone to schedule V. Section 961.22 (11), Stats., is created to read: CSB 2.010 Note961.22 (11) Ganaxolone. Ganaxolone.
CSB 2.010 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; (title) created under s. 13.92 (4) (b) 2., Stats, Register August 2022 No. 800; CR 23-021: cr. Register April 2024 No. 820, eff. 5-1-24; (title) created under s. 13.92 (4) (b) 2. Register April 2024 No. 820. CSB 2.010 NoteCSB 2.96 Addition of Amineptine to schedule I. Section 961.14 (7) (r), Stats., is created to read: CSB 2.010 Note961.14 (7) (r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine.
